Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Clinical data sources All clinical trial data cited in this report is drawn from peer-reviewed publications in The New England Journal of Medicine and The Lancet, and investor disclosures from Novo Nordisk and Eli Lilly
For instance, Kaiser Permanente plans to revise its coverage criteria starting January 1, 2025, leading to inquiries about whether Kaiser covers weight loss drugs, as it will exclude coverage for GLP-1 medications when prescribed exclusively for reducing body mass in patients with a BMI under 40
No medical treatment can guarantee outcomes
Molecules, 27 (13), 4315
US$ 21.54
US$ 20.44
US$ 28.72
US$ 28.99
